Product Browser

Last updated: 2016/12/4

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

SH3BP2 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00006452-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-SH3BP2 full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 62.2
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-SH3BP2 antibody (H00006452-B01P) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00006452-T01
    SH3BP2 transfected lysate.
    Western Blot
    QC Testing of H00006452-T01
    Lane 1: SH3BP2 transfected lysate ( 62.2 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Entrez GeneID:
  • 6452
  • Gene Name:
  • SH3BP2
  • Gene Alias:
  • 3BP2,CRBM,CRPM,FLJ42079,RES4-23
  • Gene Description:
  • SH3-domain binding protein 2
  • Gene Summary:
  • The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases , and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq
  • Other Designations:
  • -
  • Related Disease
  • RSS
  • YouTube
  • Linkedin
  • Facebook